Takeda Pharmaceutical's IFRS net income for 3 months of fiscal year 2021 was JP¥200.421 billion, up 2.4 times from JP¥82.519 billion in the previous year. Revenue rose 18.4% to JP¥949.603 billion compared to JP¥801.85 billion a year earlier.